Клинико-экономические особенности применения гепатопротекторов для лечении больных с токсическим гепатитом

Abstract

The qualification work is devoted to the clinical and economic features of the use of hepatoprotectors for the treatment of patients with toxic hepatitis. Analyzed hepatotropic drugs in the pharmaceutical market of Ukraine, their presence in medical and technological documents, studied the evidence base of clinical efficacy and analyzed the "cost minimization" of ursodeoxycholic acid. The work is presented on 44 pages of printed text and consists of an introduction, three chapters, conclusions, a list of references, an appendix. The work is illustrated with 1 figure and 6 tables, contains 55 literature sources.